Adenosine receptor ligands: Differences with acute versus chronic treatment

被引:226
作者
Jacobson, KA
vonLubitz, DKJE
Daly, JW
Fredholm, BB
机构
[1] KAROLINSKA INST, DEPT PHYSIOL & PHARMACOL, SECT MOL NEUROPHARMACOL, S-17177 STOCKHOLM, SWEDEN
[2] NIDDKD, BIOORGAN CHEM LAB, NIH, BETHESDA, MD 20892 USA
关键词
D O I
10.1016/0165-6147(96)10002-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine receptors have been the target of intense research with respect to potential use of selective ligands in a variety of therapeutic areas. Caffeine and theophylline are adenosine receptor antagonists, and over the past three decades a wide range of selective agonists and antagonists for adenosine receptor subtypes have been developed. A complication to the therapeutic use of adenosine receptor ligands is the observation that the effects of acute administration of a particular ligand can be diametrically opposite to the chronic effects of the same ligand. This 'effect inversion' is discussed here by Ken Jacobson and colleagues, and has been observed for effects on cognitive processes, seizures and ischaemic damage.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 50 条
[1]   CROSS-TOLERANCE STUDIES BETWEEN CAFFEINE AND "(-)-N-6-(PHENYLISOPROPYL)-ADENOSINE (PIA) IN MICE [J].
AHLIJANIAN, MK ;
TAKEMORI, AE .
LIFE SCIENCES, 1986, 38 (07) :577-588
[2]  
BONA E, 1995, PEDIATR RES, V38, P312, DOI 10.1203/00006450-199509000-00007
[3]  
CASATI C, 1994, J PHARMACOL EXP THER, V268, P1506
[4]  
Daly J, 1993, CAFFEINE COFFEE HLTH, P97
[5]  
Daly John W, 1994, Pharmacopsychoecologia, V7, P201
[6]  
DUDLEY M, 1994, DRUG DEVELOP RES, V31, P266
[7]   ADENOSINE DOPAMINE INTERACTIONS IN THE BRAIN [J].
FERRE, S ;
FUXE, K ;
VONEULER, G ;
JOHANSSON, B ;
FREDHOLM, BB .
NEUROSCIENCE, 1992, 51 (03) :501-512
[8]   ADENOSINE, ADENOSINE RECEPTORS AND THE ACTIONS OF CAFFEINE [J].
FREDHOLM, BB .
PHARMACOLOGY & TOXICOLOGY, 1995, 76 (02) :93-101
[9]   CGS-15943, AN ADENOSINE-A(2) RECEPTOR ANTAGONIST, REDUCES CEREBRAL ISCHEMIC-INJURY IN THE MONGOLIAN GERBIL [J].
GAO, Y ;
PHILLIS, JW .
LIFE SCIENCES, 1994, 55 (03) :PL61-PL65
[10]   CAFFEINE CROSS-TOLERANCE TO SELECTIVE DOPAMINE D-1 AND D-2 RECEPTOR AGONISTS BUT NOT TO THEIR SYNERGISTIC INTERACTION [J].
GARRETT, BE ;
HOLTZMAN, SG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 262 (1-2) :65-75